• LAST PRICE
    0.4590
  • TODAY'S CHANGE (%)
    Trending Down-0.0043 (-0.9281%)
  • Bid / Lots
    0.4640/ 4
  • Ask / Lots
    0.4975/ 4
  • Open / Previous Close
    0.4571 / 0.4633
  • Day Range
    Low 0.4418
    High 0.4898
  • 52 Week Range
    Low 0.4418
    High 2.8169
  • Volume
    727,623
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.4633
TimeVolumeMBIO
09:32 ET1065890.4635
09:36 ET196730.4645
09:38 ET122000.4628
09:39 ET70000.442901
09:41 ET310890.4645
09:43 ET14510.4775
09:45 ET40040.4636
09:48 ET26450.465101
09:50 ET5000.466
09:54 ET100000.46429
09:56 ET4230.4526
09:57 ET1000.4526
09:59 ET38270.45
10:01 ET7500.4501
10:06 ET23000.4523
10:08 ET3530.4498
10:12 ET215560.44865
10:15 ET16000.4516
10:19 ET4000.454467
10:21 ET22050.463099
10:24 ET53070.4601
10:26 ET26000.46
10:30 ET10000.45265
10:32 ET1070.450101
10:35 ET25000.4521
10:37 ET82370.4511
10:42 ET14710.4748
10:50 ET1150.450101
10:57 ET25000.4566
11:08 ET1350.4784
11:09 ET203930.46575
11:11 ET2000.4764
11:20 ET71240.4764
11:22 ET5720.455
11:24 ET2240.4665
11:26 ET2000.4566
11:27 ET2000.4603
11:29 ET1000.4762
11:33 ET17770.4604
11:36 ET2000.4604
11:38 ET1180.4731
11:40 ET11000.459
11:42 ET46200.461
11:44 ET37470.4688
11:54 ET70330.4619
12:00 ET2000.4576
12:03 ET3720.4577
12:07 ET3470.4635
12:09 ET16200.46825
12:12 ET3000.46
12:14 ET4430.4619
12:16 ET20000.4576
12:18 ET44610.4576
12:20 ET13700.4565
12:21 ET9620.4565
12:25 ET1000.4566
12:27 ET1410.4673
12:30 ET2000.4555
12:38 ET19960.4556
12:39 ET2000.459
12:41 ET10000.4596
12:50 ET2000.4596
12:54 ET11000.4595
12:56 ET14000.4571
12:57 ET2000.4556
12:59 ET10000.4556
01:01 ET2000.4555
01:03 ET1000.4555
01:08 ET1000.46775
01:14 ET1688360.469
01:15 ET55070.46
01:19 ET75000.4601
01:24 ET1000.46
01:26 ET6000.47
01:28 ET41970.4606
01:37 ET9300.47
01:42 ET1890.4768
01:44 ET2970.47
01:46 ET2000.47
01:50 ET1000.47
01:53 ET1000.47
01:55 ET9700.465
02:00 ET3000.4601
02:06 ET23340.46
02:08 ET11000.4697
02:11 ET21000.46
02:13 ET8850.4697
02:15 ET19030.46195
02:18 ET3000.462
02:20 ET51000.4609
02:22 ET46000.4602
02:24 ET7370.4602
02:27 ET5000.4601
02:29 ET4970.46
02:33 ET2000.4601
02:36 ET5000.46
02:40 ET5000.4588
02:42 ET6940.45715
02:44 ET115060.4515
02:49 ET3000.4534
02:51 ET6910.4515
02:54 ET4000.4534
03:00 ET1000.4525
03:02 ET105750.4544
03:05 ET8000.4544
03:07 ET3500.457946
03:16 ET1000.4511
03:20 ET2170.451
03:21 ET4000.4639
03:27 ET2000.462899
03:32 ET3750.457
03:39 ET442200.4531
03:41 ET151610.4521
03:43 ET136420.4501
03:45 ET8000.4532
03:48 ET19420.4619
03:50 ET17000.46
03:52 ET13000.45
03:54 ET114150.459
03:56 ET14500.45
03:57 ET2000.452
03:59 ET35750.459
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMBIO
Mustang Bio Inc
48.3M
-0.6x
---
United StatesINAB
IN8BIO, Inc.
48.7M
-1.7x
---
United StatesSNPX
Synaptogenix Inc
47.5M
-3.3x
---
United StatesMACK
Merrimack Pharmaceuticals Inc
49.6M
-30.8x
---
United StatesNERV
Minerva Neurosciences Inc
49.8M
-1.0x
---
United StatesFRLN
Freeline Therapeutics Holdings PLC
50.0M
-0.3x
---
As of 2022-09-25

Company Information

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company that is focused on translating medical breakthroughs in cell and gene therapies into cures for hematologic cancers, solid tumors and rare genetic diseases. The Company's pipeline is focused on three core areas: gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. Its products include MB-107 and MB-207 is an Ex vivo Lentiviral Therapy for X-linked Severe Combined Immunodeficiency (XSCID). XSCID is a rare genetic immune system condition also known as bubble boy disease. It is developing CAR T therapies for hematologic malignancies in partnership with COH targeting CD123 (MB-102) and CS1 (MB-104) and with Fred Hutch targeting CD20 (MB-106). The Company is also developing CAR T therapies for solid tumors in partnership with COH targeting IL13Ra2 (MB-101), HER2 (MB-103) and PSCA (MB-105).

Contact Information

Headquarters
2 Gansevoort St Fl 9NEW YORK, NY, United States 10014-1667
Phone
781-652-4507
Fax
302-531-3150

Executives

Executive Chairman of the Board
Michael Weiss
President, Chief Executive Officer, Director
Manuel Litchman
Interim Chief Financial Officer
Eliot Lurier
Director
Lindsay Rosenwald
Independent Director
Adam Chill

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$48.3M
Revenue (TTM)
$0.00
Shares Outstanding
105.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.62
EPS
$-0.79
Book Value
$1.19
P/E Ratio
-0.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.